General Pharmaceuticals Limited

POWER SEARCH PRICING

SOLUTIONS

general pharmaceuticals limited Company Information

Live

MatureSmallDeclining

Company Number

05019416

Website

www.generalpharma.com

Registered Address

32 woodstock grove, shepherds bush, london, W12 8LE

Industry

Wholesale of pharmaceutical goods

Telephone

Next Accounts Due

January 2025

Group Structure

View All

Directors

Ziad Tokatly20 Years

Gloria Tokatly8 Years

Shareholders

mr ziad tokatly 50%

mrs gloria tokatly 50%

general pharmaceuticals limited Estimated Valuation

£389.5k

Pomanda estimates the enterprise value of GENERAL PHARMACEUTICALS LIMITED at £389.5k based on a Turnover of £866k and 0.45x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

General Pharmaceuticals Limited is a live company located in london, W12 8LE with a Companies House number of 05019416. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in January 2004, it's largest shareholder is mr ziad tokatly with a 50% stake. General Pharmaceuticals Limited is a mature, small sized company, Pomanda has estimated its turnover at £866k with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded General Pharmaceuticals Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 8 areas for improvement. Company Health Check FAQs

Health Rating2out of 5

2 Strong

2 Regular

8 Weak

Size

annual sales of £866k, make it smaller than the average company (£24.6m)

Growth

3 year (CAGR) sales growth of -34%, show it is growing at a slower rate (4.7%)

EXPORT

General Pharmaceuticals Limited's latest turnover from April 2023 is estimated at £866 thousand and the company has net assets of £153.1 thousand. According to their latest financial statements, General Pharmaceuticals Limited has 2 employees and maintains cash reserves of £63.9 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Turnover	865,993	1,049,869	2,831,214	3,019,839	2,034,440	4,908,262	3,213,231	2,103,736	5,273,503	3,950,448	5,086,885	3,565,250	1,373,073	1,163,562
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	756,556	928,071	2,492,298	2,656,067	1,795,902	4,367,526	2,866,584	1,828,825	4,587,335	3,460,497	4,504,166	3,196,193	1,235,323	1,040,966
Gross Profit	109,437	121,798	338,917	363,772	238,537	540,736	346,647	274,910	686,168	489,951	582,719	369,057	137,749	122,596
Admin Expenses	322,931	562,734	345,689	454,820	-273,135	173,660	135,720	270,302	892,015	868,265	527,168	-390,656	116,103	110,303
Operating Profit	-213,494	-440,936	-6,772	-91,048	511,672	367,076	210,927	4,608	-205,847	-378,314	55,551	759,713	21,646	12,293
Interest Payable	0	0	0	0	0	26,518	35,247	10,139	0	0	0	0	0	0
Interest Receivable	3,762	424	144	572	3,711	759	222	757	910	2,679	3,192	1,198	884	373
Pre-Tax Profit	-209,732	-440,512	-6,628	-90,476	515,383	341,316	175,902	-4,773	-204,937	-375,635	58,743	760,912	22,530	12,667
Tax	0	0	0	0	-97,923	-64,850	-33,421	0	0	0	-13,511	-182,619	-5,858	-3,547
Profit After Tax	-209,732	-440,512	-6,628	-90,476	417,460	276,466	142,481	-4,773	-204,937	-375,635	45,232	578,293	16,672	9,120
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-209,732	-440,512	-6,628	-90,476	417,460	276,466	142,481	-4,773	-204,937	-375,635	45,232	578,293	16,672	9,120
Employee Costs	137,925	127,154	119,727	112,960	107,833	114,830	99,531	134,769	256,305	165,045	202,027	164,286	78,529	77,885
Number Of Employees	2	2	2	2	2	2	2	3	6	4	5	4	2	2
EBITDA*	-202,931	-428,281	29,371	-53,228	558,884	371,585	210,927	8,961	-201,658	-374,009	60,934	763,028	23,172	14,306

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Tangible Assets	30,787	37,968	48,096	79,530	105,553	6,647	11,156	15,675	16,754	17,224	21,529	9,944	4,579	5,610
Intangible Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	30,787	37,968	48,096	79,530	105,553	6,647	11,156	15,675	16,754	17,224	21,529	9,944	4,579	5,610
Stock & work in progress	23,700	80,807	110,598	368,337	199,134	45,023	27,107	70,149	58,100	54,700	49,225	42,500	46,155	4,463
Trade Debtors	321,795	405,690	1,260,897	976,586	654,911	1,690,926	1,060,613	522,369	1,437,881	1,171,161	1,255,889	1,122,275	291,637	286,605
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	0	0	0	540,589	130,699	698,366	1,152,950	648,609	0	0	0	0	0	0
Cash	63,942	113,077	0	288,465	855,005	134,528	168,890	8,771	294,202	69,966	1,001,617	275,018	204,361	149,301
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	409,437	599,574	1,371,495	2,173,977	1,839,749	2,568,843	2,409,560	1,249,898	1,790,183	1,295,827	2,306,731	1,439,793	542,153	440,369
total assets	440,224	637,542	1,419,591	2,253,507	1,945,302	2,575,490	2,420,716	1,265,573	1,806,937	1,313,051	2,328,260	1,449,737	546,732	445,979
Bank overdraft	0	0	0	0	0	0	815,945	311,961	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	287,093	274,679	616,216	1,205,765	772,304	1,976,160	1,300,608	817,384	1,738,092	1,039,269	1,678,843	845,552	520,840	436,759
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	0	0	0	161,586	178,983	116,311	97,610	72,156	0	0	0	0	0	0
total current liabilities	287,093	274,679	616,216	1,367,351	951,287	2,092,471	2,214,163	1,201,501	1,738,092	1,039,269	1,678,843	845,552	520,840	436,759
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	76,153	93,536	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	76,153	93,536	0	0	0	0	0	0	0	0	0
total liabilities	287,093	274,679	616,216	1,443,504	1,044,823	2,092,471	2,214,163	1,201,501	1,738,092	1,039,269	1,678,843	845,552	520,840	436,759
net assets	153,131	362,863	803,375	810,003	900,479	483,019	206,553	64,072	68,845	273,782	649,417	604,185	25,892	9,220
total shareholders funds	153,131	362,863	803,375	810,003	900,479	483,019	206,553	64,072	68,845	273,782	649,417	604,185	25,892	9,220

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Operating Activities
Operating Profit	-213,494	-440,936	-6,772	-91,048	511,672	367,076	210,927	4,608	-205,847	-378,314	55,551	759,713	21,646	12,293
Depreciation	10,563	12,655	36,143	37,820	47,212	4,509	0	4,353	4,189	4,305	5,383	3,315	1,526	2,013
Amortisation	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Tax	0	0	0	0	-97,923	-64,850	-33,421	0	0	0	-13,511	-182,619	-5,858	-3,547
Stock	-57,107	-29,791	-257,739	169,203	154,111	17,916	-43,042	12,049	3,400	5,475	6,725	-3,655	41,692	4,463
Debtors	-83,895	-855,207	-256,278	731,565	-1,603,682	175,729	1,042,585	-266,903	266,720	-84,728	133,614	830,638	5,032	286,605
Creditors	12,414	-341,537	-589,549	433,461	-1,203,856	675,552	483,224	-920,708	698,823	-639,574	833,291	324,712	84,081	436,759
Accruals and Deferred Income	0	0	-161,586	-17,397	62,672	18,701	25,454	72,156	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-49,515	115,180	-207,747	-537,932	769,348	807,343	-313,359	-584,737	227,045	-934,330	740,375	78,138	54,671	156,450
Investing Activities
capital expenditure	-3,382	-2,527	-4,709	-11,797	-146,118	0	4,519	-3,274	-3,719	0	-16,968	-8,680	-495	-7,623
Change in Investments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-3,382	-2,527	-4,709	-11,797	-146,118	0	4,519	-3,274	-3,719	0	-16,968	-8,680	-495	-7,623
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	-76,153	-17,383	93,536	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	0	0	0	100
interest	3,762	424	144	572	3,711	-25,759	-35,025	-9,382	910	2,679	3,192	1,198	884	373
cash flow from financing	3,762	424	-76,009	-16,811	97,247	-25,759	-35,025	-9,382	910	2,679	3,192	1,198	884	473
cash and cash equivalents
cash	-49,135	113,077	-288,465	-566,540	720,477	-34,362	160,119	-285,431	224,236	-931,651	726,599	70,657	55,060	149,301
overdraft	0	0	0	0	0	-815,945	503,984	311,961	0	0	0	0	0	0
change in cash	-49,135	113,077	-288,465	-566,540	720,477	781,583	-343,865	-597,392	224,236	-931,651	726,599	70,657	55,060	149,301

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for general pharmaceuticals limited. Get real-time insights into general pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for general pharmaceuticals limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

GENERAL PHARMACEUTICALS LIMITED group structure

General Pharmaceuticals Limited has no subsidiary companies.

Ultimate parent company

GENERAL PHARMACEUTICALS LIMITED

05019416

GENERAL PHARMACEUTICALS LIMITED Shareholders

mr ziad tokatly	50%
mrs gloria tokatly	50%

General Pharmaceuticals Limited currently has 2 directors. The longest serving directors include Mr Ziad Tokatly (Jan 2004) and Ms Gloria Tokatly (Apr 2016).

officer	country	age	start	end	role
Mr Ziad Tokatly	United Kingdom	49 years	Jan 2004	-	Director
Ms Gloria Tokatly	United Kingdom	44 years	Apr 2016	-	Director

P&L

April 2023

turnover

866k

-18%

operating profit

-213.5k

gross margin

12.7%

+8.93%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2023

net assets

153.1k

-0.58%

total assets

440.2k

-0.31%

cash

63.9k

-0.43%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

zelens limited

3.5

abbott healthcare products ltd

1.5

dasapharm limited

mensana pharma ltd.

3.5

flamingo pharma (uk) ltd

3.5

company number

05019416

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

January 2004

age

accounts

Unaudited Abridged

ultimate parent company

None

previous names

N/A

incorporated

address

32 woodstock grove, shepherds bush, london, W12 8LE

last accounts submitted

April 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to general pharmaceuticals limited. Currently there are 2 open charges and 0 have been satisfied in the past.

general pharmaceuticals limited Company Information

general pharmaceuticals limited Estimated Valuation

general pharmaceuticals limited Estimated Valuation

general pharmaceuticals limited Estimated Valuation

General Pharmaceuticals Limited Overview

General Pharmaceuticals Limited Health Check

GENERAL PHARMACEUTICALS LIMITED financials

general pharmaceuticals limited Credit Report and Business Information

General Pharmaceuticals Limited Competitor Analysis

general pharmaceuticals limited Ownership

general pharmaceuticals limited directors

general pharmaceuticals limited company details

general pharmaceuticals limited Charges & Mortgages

general pharmaceuticals limited Companies House Filings - See Documents